Warfarin Tablet Uses in Pakistan

Warfarin (Warf / Coumadin) is used in Pakistan for the treatment and prevention of blood clots. This guide covers all approved uses, indications, and essential safety information.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-06-17

Uses

Quick Answer

Warfarin (Warf / Coumadin) is used to prevent and treat blood clots: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation stroke prevention, mechanical heart valve anticoagulation, and post-surgical thromboembolism prevention. It thins the blood by blocking Vitamin K-dependent clotting factors. Always take as prescribed — INR monitoring is mandatory.

Primary Uses at a Glance

Deep Vein Thrombosis (DVT) — Treatment and Prevention

Warfarin is used for the treatment of DVT and to prevent recurrence. After bridge therapy with LMWH (heparin), warfarin is started and INR is brought into the therapeutic range (2.0–3.0).

As prescribed by doctor. INR target 2.0–3.0. Dose is adjusted by the doctor based on INR results.

Pulmonary Embolism (PE) — Treatment and Prevention

In PE, a clot forms in the blood vessels of the lungs — this is a life-threatening emergency. Warfarin is used for long-term prevention after hospital treatment. INR target range 2.0–3.0.

As prescribed by specialist. Minimum 3–6 months; longer if recurrent or unprovoked.

Atrial Fibrillation (AF) — Stroke Prevention

In AF, the irregular heartbeat can cause a blood clot that travels to the brain and causes a stroke. Warfarin dramatically reduces this risk. This is the most common indication in Pakistan.

As prescribed. INR target 2.0–3.0. Doctor decides based on risk stratification (CHA₂DS₂-VASc score).

Mechanical Heart Valves — Lifelong Anticoagulation

Clots can form on artificial (mechanical) heart valves. Warfarin must be taken lifelong — the INR target is higher for this indication. DOACs are contraindicated in mechanical valves.

Lifelong — as prescribed by cardiologist. INR target depends on valve type (2.5–3.5 standard).

Post-surgical Venous Thromboembolism Prevention

Warfarin or LMWH is used for DVT/PE prevention after major orthopedic (hip/knee replacement) or abdominal surgery. Duration depends on surgery type and risk factors.

As prescribed by surgeon/physician — typically short-term (2–6 weeks post-surgery).

Recurrent Thromboembolism Prevention

Patients who repeatedly develop DVT or PE are given long-term or indefinite warfarin. The risk-benefit assessment is done by the doctor.

Long-term or indefinite — as prescribed by haematologist or physician.

Other Uses

Antiphospholipid syndrome (APS) — mandatory warfarin, not DOAC
Cerebral sinus venous thrombosis
Portal vein thrombosis

Warfarin Tablet Uses (Fayde / Kis kaam aati hai)

Warfarin (Warf / Coumadin) contains Warfarin as the active ingredient and belongs to the Vitamin K Antagonist (VKA) Anticoagulant class. Below are all approved and common uses of this medicine in Pakistan.

Primary Uses (Mukhya Istemal)

Deep Vein Thrombosis (DVT) — treatment and prevention
Pulmonary Embolism (PE) — treatment and prevention
Atrial Fibrillation (AF) — stroke prevention
Mechanical heart valves — lifelong anticoagulation (artificial valve protection)
Venous thromboembolism prevention — after surgery
Recurrent thromboembolism — prevention of repeated clots

INR Monitoring — Samajh lein (Zaroori Maloomat)

The effect of Warfarin is measured using the INR (International Normalized Ratio) blood test:

INR Range	Matlab
INR < 2.0	Under-anticoagulated — clot risk
INR 2.0–3.0	Therapeutic range (DVT/PE/AF)
INR 2.5–3.5	Therapeutic range (mechanical valves)
INR > 4.0	Over-anticoagulated — major bleeding risk
INR > 5.0	Reversal required (Vitamin K1 / FFP)

Secondary Uses

Antiphospholipid syndrome (APS) — warfarin mandatory, not DOAC
Cerebral sinus venous thrombosis
Portal vein thrombosis

Who Should Take It (Kin logon ke liye)

Patients doctor-prescribed for DVT or PE treatment or prevention
Patients with stroke risk from atrial fibrillation
Mechanical heart valve patients — lifelong
Specialist-recommended patients for post-surgical VTE prophylaxis

When NOT to Use Warfarin (Kab nahi leni chahiye)

PREGNANCY (especially 1st trimester) — Category X teratogen; LMWH alternative
Active major bleeding
Warfarin se proven allergy
Haemorrhagic stroke history
Severe liver disease

Summary

Warfarin is prescribed for DVT, PE, AF, mechanical heart valves, and recurrent thromboembolism. The dose is always adjusted by the doctor based on INR blood test — NEVER change the dose yourself. Always take as prescribed by your doctor.

The information in this guide is for educational purposes only.

Frequently Asked Questions

Warfarin kis kaam aata hai?

Warfarin (Warf / Coumadin) is used to prevent and treat blood clots (thrombosis) — DVT, PE, stroke prevention in atrial fibrillation, and protection of mechanical heart valves. It is a Vitamin K antagonist anticoagulant.

Kya warfarin atrial fibrillation mein leni chahiye?

Atrial fibrillation carries a stroke risk — the doctor recommends warfarin or a DOAC (apixaban/rivaroxaban) based on the CHA₂DS₂-VASc score. The doctor assesses the risk-benefit and decides.

Warfarin mechanical heart valve mein kyon zaroori hai?

Blood clots can form on mechanical valves — warfarin provides lifelong protection. DOACs are not safe for patients with mechanical valves — only warfarin is approved. INR target is 2.5–3.5.

Warfarin kitne time tak leni hoti hai?

Duration depends on the indication: DVT/PE 3–6 months (provoked), indefinite if unprovoked or recurrent. Usually lifelong in AF. Lifelong in mechanical valves. The doctor decides.

Kya warfarin ki jagah koi aur medicine le sakte hain?

Yes — DOACs (apixaban, rivaroxaban, dabigatran) are a better option than warfarin for AF and VTE (no INR monitoring required). However, only warfarin is approved for mechanical valves and APS.

Brand alternatives, same-class options, and other medicines used for the same conditions as Warfarin Tablet.

Other supplements and vitamins

Sibling medicines in the Supplements and Vitamins class.

All in class →

Sources

DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.